Roopa Industries

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE443C01010
  • NSEID:
  • BSEID: 530991
INR
50.00
-2.74 (-5.2%)
BSENSE

Jul 15, 11:20 AM

BSE+NSE Vol: 502

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

502 (12.00%) Volume

Shareholding (Mar 2026)

FII

0.25%

Held by 1 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

48.03%

Why is Roopa Industries Ltd falling/rising?

15-Jul-2026

As of 14-Jul, Roopa Industries Ltd's stock price has risen to Rs 52.74, reflecting a 3.43% increase. This growth is driven by strong historical performance, positive trading activity, and increased investor interest, significantly outperforming the Sensex.

As of 14-Jul, Roopa Industries Ltd is experiencing a rise in its stock price, currently at Rs 52.74, which reflects an increase of Rs 1.75 or 3.43%. This upward movement can be attributed to several factors. Over the past week, the stock has gained 6.33%, significantly outperforming the Sensex, which has declined by 1.44%. In the last month, Roopa Industries has shown an impressive return of 11.52%, while the Sensex has only increased by 2.02%.<BR><BR>Year-to-date, the stock has risen by 19.75%, contrasting sharply with the Sensex's decline of 9.58%. Additionally, over the last three years, Roopa Industries has delivered a return of 32.02%, compared to the Sensex's 16.64%. The stock's performance over the last five years is particularly notable, with a staggering increase of 257.56% against the Sensex's 45.65%.<BR><BR>Today's trading activity indicates a strong performance, as the stock has outperformed its sector by 2.67% and has been on a consecutive gain streak for the last two days, accumulating a total return of 13.05% during this period. Although the stock opened lower today, with a gap down of 5.86%, it managed to reach an intraday high of Rs 53, reflecting a rise of 3.94%. The trading volume has also seen a positive trend, with delivery volume increasing by 22.33% compared to the five-day average, indicating rising investor participation.<BR><BR>Furthermore, Roopa Industries is trading above its moving averages across various time frames (5-day, 20-day, 50-day, 100-day, and 200-day), which is a bullish signal. Overall, the combination of strong historical performance, positive trading activity, and increased investor interest contributes to the rising stock price of Roopa Industries Ltd.

View full answer

Should I buy, sell or hold Roopa Industries Ltd?

17-Jun-2026

How big is Roopa Industries?

11-Jun-2026

As of 10th June, Roopa Industries Ltd has a market capitalization of 39.00 Cr, with recent net sales of 127.49 Cr and a net profit of 0.08 Cr. Shareholder's funds are 17.49 Cr, and total assets amount to 76.46 Cr as of March 2025.

As of 10th June, Roopa Industries Ltd has a market capitalization of 39.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest 4 quarters, Roopa Industries reported Net Sales of 127.49 Cr and a Net Profit of 0.08 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 17.49 Cr and Total Assets of 76.46 Cr.

View full answer

Who are in the management team of Roopa Industries?

11-Jun-2026

The management team of Roopa Industries includes T G Raghavendra (Chairman & Managing Director), V J Sarma (Whole-time Director), and three Non-Executive & Independent Directors: O Mohan Rao, A Satyanarayana Murthy, and Karunasree.

The management team of Roopa Industries includes the following individuals:<BR><BR>1. T G Raghavendra - Chairman & Managing Director<BR>2. V J Sarma - Whole-time Director<BR>3. O Mohan Rao - Non-Executive & Independent Director<BR>4. A Satyanarayana Murthy - Non-Executive & Independent Director<BR>5. Karunasree - Non-Executive & Independent Director<BR><BR>If you need more details about their roles or the company, feel free to ask!

View full answer

Who are the peers of the Roopa Industries?

11-Jun-2026

Roopa Industries' peers include Mangalam Drugs, Sandu Pharma, Murae Organisor, Lasa Supergeneri, ANG Lifesciences, Medi Caps, Chandra Bhagat, Welcure Drugs, and Guj. Terce Labs. ANG Lifesciences has the highest 1-year return at -7.18%, while Mangalam Drugs has the lowest at -65.43%, with Roopa Industries at -23.66%.

Peers: The peers of Roopa Industries are Mangalam Drugs, Sandu Pharma., Murae Organisor, Lasa Supergeneri, ANG Lifesciences, Medi Caps, Chandra Bhagat, Welcure Drugs, and Guj. Terce Labs.<BR><BR>Quality Snapshot: Excellent growth is observed at Roopa Industries, while Below Average management risk is found at Mangalam Drugs, Sandu Pharma., Murae Organisor, Lasa Supergeneri, ANG Lifesciences, Medi Caps, Chandra Bhagat, Guj. Terce Labs., and the rest. Average capital structure is noted at Sandu Pharma. and Welcure Drugs, while Good capital structure is seen at Sandu Pharma. and Medi Caps, with the rest having Below Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is ANG Lifesciences at -7.18%, while the peer with the lowest 1-year return is Mangalam Drugs at -65.43%. Roopa Industries has a 1-year return of -23.66%, which is better than Mangalam Drugs but worse than ANG Lifesciences. Additionally, several peers, including Murae Organisor, Lasa Supergeneri, Welcure Drugs, and Guj. Terce Labs., have negative six-month returns.

View full answer

What does Roopa Industries do?

10-Jun-2026

Roopa Industries Ltd manufactures bulk drugs and drug intermediates in the Pharmaceuticals & Biotechnology sector. As of March 2026, it reported net sales of 30 Cr and a net profit of -1 Cr, with a market cap of INR 39 Cr.

Overview: <BR>Roopa Industries Ltd is engaged in the manufacturing of bulk drugs and drug intermediates within the Pharmaceuticals & Biotechnology industry, categorized as a Micro Cap company.<BR><BR>History: <BR>Roopa Industries Limited was incorporated in 1985 as "Roopa Granites Private Limited," changed to "Roopa Granites Limited" in 1992, and further renamed to M/s. Roopa Industries in 1994. The latest quarterly results report net sales and profit for March 2026.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 30 Cr (Quarterly Results - Mar 2026) <BR>Most recent Net Profit: -1 Cr (Quarterly Results - Mar 2026) <BR>Market-cap value: INR 39 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 9.00 <BR>Industry P/E: 34 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 1.68 <BR>Return on Equity: 23.69% <BR>Price to Book: 2.19 <BR><BR>Contact Details: <BR>Address: 17/745 Alur Road, Kurnool District ADONI Andhra Pradesh : 518301 <BR>Fax: 91-40-23310379 <BR>Email: info@roopaindustries.com <BR>Website: http://www.roopaindustries.com

View full answer

Are Roopa Industries Ltd latest results good or bad?

02-Jun-2026

Roopa Industries Ltd's latest results show improved operational efficiency with a highest operating margin of 10.19%, but the company reported a net loss of ₹1.43 crores, contrasting with a profit in the previous quarter, raising concerns about its growth sustainability. While there are operational gains, the decline in revenue and net loss indicate challenges ahead for investors.

Roopa Industries Ltd's latest results for Q4 FY26 present a mixed picture. On one hand, the company achieved its highest operating margin in eight quarters at 10.19%, indicating improved operational efficiency. However, this positive operational performance was overshadowed by a significant net loss of ₹1.43 crores, a stark contrast to the profit of ₹0.77 crores reported in the previous quarter (Q3 FY26).<BR><BR>Revenue for the quarter was ₹30.14 crores, which reflects a 10.14% decline compared to the previous quarter but shows a slight year-on-year increase of 1.04%. The negative net profit and declining revenue raise concerns about the sustainability of the company's growth, especially given the high leverage ratios and working capital pressures it faces.<BR><BR>Overall, while Roopa Industries has demonstrated operational improvements, the recent loss at the net profit level suggests challenges that investors should carefully consider. The company's ability to maintain these operational gains while returning to profitability will be crucial moving forward.

View full answer

When is the next results date for Roopa Industries Ltd?

21-May-2026

The next results date for Roopa Industries Ltd is 30 May 2026.

The next results date for Roopa Industries Ltd is scheduled for 30 May 2026.

View full answer

How has been the historical performance of Roopa Industries?

14-Nov-2025

Roopa Industries has shown significant growth in net sales, increasing from 26.58 Cr in Mar'21 to 120.69 Cr in Mar'25, with profits also rising, despite a sharp increase in raw material costs. Operating profit reached 6.41 Cr in Mar'25, and profit after tax rose to 2.03 Cr, while total assets and liabilities grew to 76.46 Cr each.

Answer:<BR>The historical performance of Roopa Industries shows significant growth in net sales and profit over the years.<BR><BR>Breakdown:<BR>Roopa Industries has demonstrated a strong upward trend in net sales, increasing from 26.58 Cr in Mar'21 to 120.69 Cr in Mar'25, with a notable jump from 70.43 Cr in Mar'24. The total operating income followed a similar trajectory, reaching 120.69 Cr in Mar'25, up from 70.43 Cr in the previous year. However, raw material costs surged to 114.42 Cr in Mar'25, reflecting a substantial increase from 47.06 Cr in Mar'24. Despite this, the operating profit (PBDIT) rose to 6.41 Cr in Mar'25, compared to 5.68 Cr in Mar'24, indicating improved operational efficiency. Profit before tax also increased to 2.72 Cr in Mar'25 from 2.17 Cr in Mar'24, leading to a profit after tax of 2.03 Cr in Mar'25, up from 1.52 Cr in the prior year. The company's total assets grew to 76.46 Cr in Mar'25, while total liabilities also increased to 76.46 Cr, reflecting a balanced growth. The cash flow from operating activities showed a decline to -6.00 Cr in Mar'25, contrasting with a positive cash flow of 2.00 Cr in Mar'24, but the overall cash position improved with closing cash and cash equivalents rising to 3.00 Cr in Mar'25 from 2.00 Cr in Mar'24.

View full answer

Is Roopa Industries overvalued or undervalued?

11-Nov-2025

As of November 10, 2025, Roopa Industries is considered undervalued with a favorable PE Ratio of 18.65 and strong growth potential, making it a compelling investment opportunity compared to its peers, despite recent stock performance lagging behind the Sensex.

As of 10 November 2025, Roopa Industries has moved from an attractive to a very attractive valuation grade. The company is currently considered undervalued. Key ratios include a PE Ratio of 18.65, an EV to EBITDA of 14.98, and a PEG Ratio of 0.75, indicating strong potential for growth relative to its price.<BR><BR>In comparison to peers, Roopa Industries shows a more favorable valuation than Sun Pharma, which has a PE Ratio of 35.15 and is deemed expensive, as well as Divi's Lab, which is classified as very expensive with a PE Ratio of 71.55. Despite recent stock performance lagging behind the Sensex, particularly with a year-to-date return of -33.75% compared to the Sensex's 6.91%, the overall valuation metrics suggest that Roopa Industries presents a compelling investment opportunity.

View full answer

Who are the top shareholders of the Roopa Industries?

17-Jul-2025

The top shareholders of Roopa Industries are Star Niochem Pvt Limited with 18.91%, followed by public shareholder Sangeetha S at 9.51%. Individual investors own 40.95%, and there is one foreign institutional investor with a 0.25% stake, with no pledged promoter holdings or mutual funds involved.

The top shareholders of Roopa Industries include Star Niochem Pvt Limited, which holds the largest stake at 18.91%. Following that, the highest public shareholder is Sangeetha S, with a holding of 9.51%. Additionally, individual investors collectively own 40.95% of the company. There is also one foreign institutional investor (FII) with a 0.25% stake. Notably, there are no pledged promoter holdings or mutual funds involved in this company.

View full answer

What is the technical trend for Roopa Industries?

09-Jun-2025

As of June 4, 2025, Roopa Industries shows a neutral trend with a slight bullish bias, indicated by mixed signals from the MACD and daily moving averages, while weekly indicators suggest upward momentum.

As of 4 June 2025, the technical trend for Roopa Industries has changed from mildly bearish to sideways. The weekly MACD is mildly bullish, while the monthly MACD is mildly bearish, indicating mixed signals. The Bollinger Bands are mildly bullish on both the weekly and monthly time frames, suggesting some upward momentum. However, the daily moving averages are mildly bearish, which adds a cautionary note. The KST and Dow Theory are both mildly bullish on the weekly and monthly charts, reinforcing some positive sentiment. Overall, the current stance is neutral with a slight bullish bias, driven primarily by the weekly indicators.

View full answer

Has Roopa Industries declared dividend?

06-Jun-2025

No Dividend History Available

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 8.82%

  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 3.82 times
2

With a growth in Operating Profit of 56.65%, the company declared Very Positive results in Mar 26

3

With ROCE of 15.6, it has a Very Attractive valuation with a 1.5 Enterprise value to Capital Employed

4

Majority shareholders : Non Institution

 
5

Below par performance in long term as well as near term

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 39 Cr (Micro Cap)

stock-summary
P/E

10.00

stock-summary
Industry P/E

36

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

1.68

stock-summary
Return on Equity

23.69%

stock-summary
Price to Book

2.36

Revenue and Profits:
Net Sales:
30 Cr
(Quarterly Results - Mar 2026)
Net Profit:
-1 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-6.98%
0%
-6.98%
6 Months
2.61%
0%
2.61%
1 Year
-13.79%
0%
-13.79%
2 Years
-16.67%
0%
-16.67%
3 Years
25.16%
0%
25.16%
4 Years
41.44%
0%
41.44%
5 Years
238.98%
0%
238.98%

Roopa Industries for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

11-Jul-2026 | Source : BSE

Submission of Certificate U/R 74(5) of SEBI (DP) Regulations 2018

Closure of Trading Window

25-Jun-2026 | Source : BSE

Intimation of Closure of Trading Window for the quarter ended 30 June 2026

Submission Of Newspaper Clipping Pursuant To SEBI Circular No. SEBI/HO/38/13/11(2)2026- MIRSD-Pod/1/3750/2026 Dated January 30 2026

15-Jun-2026 | Source : BSE

Submission of Newspaper Clipping

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
36.83%
EBIT Growth (5y)
53.31%
EBIT to Interest (avg)
0.97
Debt to EBITDA (avg)
5.04
Net Debt to Equity (avg)
1.68
Sales to Capital Employed (avg)
1.95
Tax Ratio
44.44%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.26%
ROCE (avg)
6.58%
ROE (avg)
12.56%

Valuation key factors

Factor
Value
P/E Ratio
10
Industry P/E
36
Price to Book Value
2.36
EV to EBIT
9.67
EV to EBITDA
8.73
EV to Capital Employed
1.51
EV to Sales
0.56
PEG Ratio
0.09
Dividend Yield
NA
ROCE (Latest)
15.59%
ROE (Latest)
23.69%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bearish
Dow Theory
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 1 FIIs (0.25%)

Promoter with highest holding

Star Niochem Pvt Limited (18.91%)

Highest Public shareholder

Sangeetha S (9.51%)

Individual Investors Holdings

41.0%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -10.14% vs 16.70% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is -285.71% vs 67.39% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "30.14",
          "val2": "33.54",
          "chgp": "-10.14%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.07",
          "val2": "2.03",
          "chgp": "51.23%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.74",
          "val2": "0.79",
          "chgp": "-6.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-4.09",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-1.43",
          "val2": "0.77",
          "chgp": "-285.71%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "10.19%",
          "val2": "6.05%",
          "chgp": "4.14%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 6.15% vs 106.60% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -12.79% vs 7.50% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "63.82",
          "val2": "60.12",
          "chgp": "6.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "3.04",
          "val2": "2.69",
          "chgp": "13.01%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1.69",
          "val2": "1.50",
          "chgp": "12.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.75",
          "val2": "0.86",
          "chgp": "-12.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.76%",
          "val2": "4.47%",
          "chgp": "0.29%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 7.17% vs 87.94% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -6.17% vs 51.40% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "97.36",
          "val2": "90.85",
          "chgp": "7.17%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.07",
          "val2": "3.66",
          "chgp": "38.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.48",
          "val2": "2.17",
          "chgp": "14.29%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "1.52",
          "val2": "1.62",
          "chgp": "-6.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "5.21%",
          "val2": "4.03%",
          "chgp": "1.18%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 5.64% vs 71.36% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is -96.06% vs 33.55% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "127.50",
          "val2": "120.69",
          "chgp": "5.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "8.15",
          "val2": "4.11",
          "chgp": "98.30%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "3.22",
          "val2": "2.83",
          "chgp": "13.78%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-4.09",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.08",
          "val2": "2.03",
          "chgp": "-96.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "6.39%",
          "val2": "3.41%",
          "chgp": "2.98%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Mar'26 - QoQstock-summary

Mar'26
Dec'25
Change(%)
Net Sales
30.14
33.54
-10.14%
Operating Profit (PBDIT) excl Other Income
3.07
2.03
51.23%
Interest
0.74
0.79
-6.33%
Exceptional Items
-4.09
0.00
Standalone Net Profit
-1.43
0.77
-285.71%
Operating Profit Margin (Excl OI)
10.19%
6.05%
4.14%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2026 is -10.14% vs 16.70% in Dec 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is -285.71% vs 67.39% in Dec 2025

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Sep'24
Change(%)
Net Sales
63.82
60.12
6.15%
Operating Profit (PBDIT) excl Other Income
3.04
2.69
13.01%
Interest
1.69
1.50
12.67%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.75
0.86
-12.79%
Operating Profit Margin (Excl OI)
4.76%
4.47%
0.29%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 6.15% vs 106.60% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is -12.79% vs 7.50% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary

Dec'25
Dec'24
Change(%)
Net Sales
97.36
90.85
7.17%
Operating Profit (PBDIT) excl Other Income
5.07
3.66
38.52%
Interest
2.48
2.17
14.29%
Exceptional Items
0.00
0.00
Standalone Net Profit
1.52
1.62
-6.17%
Operating Profit Margin (Excl OI)
5.21%
4.03%
1.18%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2025 is 7.17% vs 87.94% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is -6.17% vs 51.40% in Dec 2024

Annual Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
127.50
120.69
5.64%
Operating Profit (PBDIT) excl Other Income
8.15
4.11
98.30%
Interest
3.22
2.83
13.78%
Exceptional Items
-4.09
0.00
Standalone Net Profit
0.08
2.03
-96.06%
Operating Profit Margin (Excl OI)
6.39%
3.41%
2.98%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2026 is 5.64% vs 71.36% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2026 is -96.06% vs 33.55% in Mar 2025

stock-summaryCompany CV
About Roopa Industries Ltd stock-summary
stock-summary
Roopa Industries Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Roopa Industries Limited was incorporated 1985 as a Private Limited Company with the name "Roopa Granites Private Limited", the name of the Company was changed to "Roopa Granites Limited" in 1992 and further changed its name to M/s. Roopa Industries in 1994. The Company is engaged in manufacturing of Bulk drugs/Drug Intermediates.
Company Coordinates stock-summary
Company Details
17/745 Alur Road, Kurnool District ADONI Andhra Pradesh : 518301
stock-summary
Tel:
stock-summary
info@roopaindustries.com
Registrar Details
Aarthi Consultants Pvt Ltd, 1-2-285 , Domalaguda, Hyderabad